Search for content, post, videos

Ultimovacs strengthens IP portfolio

Carlos de Sousa
Ultimovacs has announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for the company’s US application for a patent covering methods for eliciting a T cell immune response with the UV1 universal cancer vaccine. Subject to grant formalities, the com
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.